TRI Strategic Plan 2022 - 2024

TRI connects scientists with clinicians and industry in a unique setting; providing access to research, clinical trial and manufacturing expertise, and world-class facilities that ultimately aim to translate to improved healthcare. Our goals are what we want to achieve through collaboration, leveraging our resources, looking after our people and connecting with our stakeholders.

Our Vision:

Exceptional Science. Healthier Lives. 

Our Purpose:

Transforming health through collaborative research

Our Goals:

 

 

Partnerships - Promote thriving research, clinical and industry partnerships

Key Strategies

• Map TRI research capabilities and capacity to national health priorities to enable and facilitate collaboration (1). 
• Increase connections for TRI-based scientists with clinicians and industry (2-5).
• Collaborate on grant opportunities (including Medical Research Future Fund) to address important clinical questions (1-3). 

Success Measures

1. Growth in the number and diversity of multi-partner collaborations measured by co-publications and joint grant applications by TRI-based researchers.
2. Growth in the number of TRI affiliates (across clinical, research and industry domains). 
3. Increased TRI-based researcher collaborations with industry. 
4. Increased TRI-based researchers participating in translational training programs. 
5. Ongoing engagement and linkage with startup/scaleup commercial companies based at TRI and nationally. 

 

Collaboration - Foster a collaborative environment for people and ideas to flourish 

Key Strategies

• Promote a 'One-TRI' culture through the creation of joint opportunities, initiatives and shared collaborative spaces (1-5).
• Provide a workplace that values safety, diversity, inclusion, health and wellbeing (1-3)
• Support, train and mentor our people to increase translational capability and to promote career success (4, 5).

Success Measures

1. Gender equity is represented on TRI committees and speakers/chairs at TRI-wide seminars.
2. Expanded TRI Wellbeing Committee representation to embed a One-TRI culture.
3. Growth in the number of, and participation rates in, TRI-wide wellbeing events and initiatives.
4. Growth in the number of participants in targeted TRI-wide mentoring and career development programs for EMCRs.
5. Improvements to TRI's collaborative built and social environment informed by feedback from experience and exit surveys.

 

Excellence - Achieve research excellence through access to world-class capabilities 

Key Strategies

• Maintain and facilitate access to cutting-edge research infrastructure for TRI researchers and for our collaborative networks in Queensland (1-3). 
• Develop and publicise TRI-based research excellence, infrastructure, and capabilities (1, 2, 4)
• Provide opportunities to increase capability of TRI research support and professional staff (4, 5)
• Deliver and support novel investigator-initiated, MTP industry and sponsored clinical trials (1, 3)

Success Measures

1. Growth in utilisation of core facilities, including cleanrooms and clinical research facilities by (i) internal users and (iii) external users. 
2. Increased satisfaction of users of the TRI (i) core facilities. Gender equity is represented on TRI committees and speakers/chairs at TRI-wide seminars. 
3. Growth and diversity of translational trials, both in (i) investigator-initiated clinical trials and (ii) industry-led clinical trials. 
4. Growth in the number and dollar investment of successful joint infrastructure programs at TRI. 
5. Improved retention rates and job satisfaction of research support and professional staff at TRI. 

 

Relationships - Strengthen relationships for investment in ideas, discovery and outcomes 

Key Strategies

• Promote a strong, cohesive TRI through its influence nationally and internationally by collaboration with health and medical research organisations (1-3, 5).
• Build sustainable relationships with industry and peak industry bodies (4, 5).
• Engage with community consumer networks (3, 5)
• Foster relationship with government (5).

Success Measures

1. Increased international collaborations measured by numbers of (i) publications, (ii) international grant applications.
2. Growth in the number of TRI-based occupants on key health and medical research state and national committees.
3. Growth in the number of TRI-based researchers undergoing consumer engagement training.
4. Growth in the number of TRI-based researchers collaborating with TRI-based and / or companies in industry.
5. Maintain and encourage a diverse range of high profile visits (including government, industry, university, MRI peers, and international researchers) to TRI and develop associated media and social media activity.